Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Randomized Two-Way Crossover Pilot Study To Estimate The Effects Of Inhaled Versus IV Infusion Of Human Insulin With Regards To Glucose Disposal In Subjects With Type 1 Diabetes Mellitus

NCT00287066 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00287066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00287066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Randomized Two-Way Crossover Pilot Study To Estimate The Effects Of Inhaled Versus IV Infusion Of Human Insulin With Regards To Glucose Disposal In Subjects With Type 1 Diabetes Mellitus
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Terminated
Start date
February 28, 2006
Completion date
March 31, 2007
Enrollment
22
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus